Press ReleasesMedline and Visby form distribution partnership for game-changing STI test

Medline and Visby form distribution partnership for game-changing STI test

New handheld CLIA waived PCR test allows clinicians to improve detection time for patients

By William Berger | August 2, 2022

Medline today announced a new partnership with Visby Medical (Visby), an award-winning medical diagnostic company, for distribution of Visby Medical’s Sexual Health Click Test, a groundbreaking Clinical Laboratory Improvement Amendments (CLIA) waived, PCR diagnostic test for sexually transmitted infections (STIs) for women that fits in the palm of your hand.

As STIs are at an all-time high for the sixth consecutive year in the U.S., Medline will bring this new Food and Drug Administration (FDA)-cleared technology to healthcare organizations in all 50 states and across the continuum of care, including urgent care centers, student health centers, women’s health facilities, and community health centers.

The Visby PCR point-of-care device is an all-in-one unit that requires no separate instrument or reader. Designed to provide accurate diagnosis in under 30 minutes, the Visby device enables clinicians to discuss results and prescribe personalized treatment during the patient visit – rather than days later – eliminating the need for presumptive treatment.

“Our partnership with Visby demonstrates our commitment to bringing leading-edge medical innovations to the point of care that revolutionize patient care,” said Doug Sharpe, vice president of Lab Capital at Medline. “Winning several awards for design innovation and excellence, the Visby device is the first PCR test of its kind and gives clinicians a tool to help improve patient outcomes.”

According to a recent study in The Lancet Infectious Diseases, the Visby Medical Sexual Health Click Test is potentially the new gold standard for point-of-care tests for infectious diseases such as STIs in which rapid turnaround is key. As a finalist for the 2022 AACC Disruptive Technology Award, the Visby device has ~97% accuracy or greater for the detection of chlamydia, gonorrhea, and trichomonas, the three most common pathogens that can foster contagion and permanently damage a woman’s reproductive system if left untreated.

“Visby’s development of the world’s first instrument-free handheld PCR platform to accurately and rapidly test for a variety of serious infections is changing how healthcare is delivered, especially in urgent care and women’s health settings,” said Visby Medical Founder and CEO Adam de la Zerda. “Our partnership with Medline will help our innovative testing technology reach clinicians quickly, helping us improve STI containment, prevention, and treatment.”

To learn more about the Visby Medical Sexual Health Click Test, please visit us here:

About Visby Medical™:

Visby Medical is transforming the order of diagnosis and treatment for infectious diseases so clinicians can test, talk with, and treat the patient in a single visit. The Company’s proprietary technology development program culminated in the world’s first instrument-free, single-use PCR platform that fits in the palm of your hand and rapidly tests for serious infections. Originally developed for sexually transmitted infections, the Company’s FDA-cleared, CLIA-waived Sexual Health Click Test for women returns accurate results within 28 minutes. The Visby Medical technology is also helping to fight the global pandemic via the Visby Medical COVID-19 Test, and its robust pipeline includes tests for other infectious diseases. Visby Medical is accelerating the delivery of fast and accurate, palm-sized PCR diagnostics to the point of care, and eventually for use at home. For more information, visit Follow Visby Medical on LinkedIn, Facebook, and Twitter.

About Medline:

Medline is a healthcare company; a manufacturer, distributor, and solutions provider focused on improving the overall operating performance of healthcare. Partnering with healthcare systems and facilities across the continuum of care, Medline provides the clinical and supply chain resources required for long-term financial viability in delivering high-quality care. With the scale of one of the country’s largest companies and the agility of a family-led business, Medline is able to invest in its customers for the future and rapidly respond to a dynamically changing market with customized solutions. Headquartered in Northfield, Ill., Medline has 30,000+ employees worldwide and does business in more than 125 countries and territories. Learn more about Medline at

Contact Information:

William Berger




William Berger

Media Relations Specialist

William Berger is a media relations specialist at Medline.

View All Stories From This Author